Today: 17 September 2025
3 June 2024
2 mins read

Who Should Opt for Hormone Therapy? Expert Insights

Hormonal therapy, an easily available form of treatment and consumed as a tablet, blocks these receptors or stops hormone production to curb cancer growth, reducing the risk of recurrence or metastasis…reports Asian Lite News

Hormone therapy can be an effective treatment against some breast cancers that are affected by hormones, like oestrogen and progesterone, said health experts on Friday.

Hormone therapy is different from hormone replacement therapy which can worsen breast cancer.

Though not all, some breast cancer tumours express hormone receptors, making them sensitive to hormones, and are termed hormone-sensitive breast cancers. When these receptors bind to oestrogen and progesterone, it promotes tumour growth.

Hormonal therapy, an easily available form of treatment and consumed as a tablet, blocks these receptors or stops hormone production to curb cancer growth, reducing the risk of recurrence or metastasis.

“While it is called hormonal therapy it is actually ‘anti-hormone’, aimed at reducing the level of oestrogen levels in the body, thereby preventing its action on tumour cells within the body,” Dr. Geeta Kadayaprath, Senior Consultant, Breast Surgery, Apollo Cancer Centres, New Delhi, told.

“Hormonal treatment is a very effective form of treatment against hormone-sensitive tumours. In premenopausal women, the option is to use tamoxifen, which prevents the oestrogen hormone from binding to the tumour cells whereas, in postmenopausal women, the preferred option is aromatase inhibitors which prevent the production of the hormone in the periphery, meaning fat, which is also a source of hormones,” the doctor explained.

The role of hormone therapy varies from preventive therapy in stage I-III to palliative therapy in stage IV.

“While it may not achieve a cure by itself, it plays an important and indispensable role in the treatment of hormone receptor-positive breast cancer,” Dr Tasneem Bharmal Associate Consultant, Medical Oncology Punyashlok Ahilyadevi Holkar Head and Neck Cancer Institute of India, Mumbai, told.

Who can opt for it? 

Dr. Geeta said in older women, with early-stage hormone-sensitive disease, hormonal treatment alone may be used as an adjuvant form of treatment with results equivalent to those who receive chemotherapy.

“It is also minus the side effects of chemotherapy though. However, tamoxifen is known to increase the coagulability of blood and increase uterine thickness, rarely leading to uterine cancer. In older women, aromatase inhibitors may be associated with bone pains, muscle pains, and sometimes, increased fracture risk,” she said.

Dr Tasneem noted that hormone therapies are widely available in India, “with costs ranging from Rs 200/month to Rs 10,000/month, depending on the prescribed hormone agent”.

Potential side effects include hot flashes, osteoporosis, arthralgia, mood swings, and an increased risk of blood clots.

The health experts advocated for regular self-awareness, breast self-examination, and early presentation for treatment which are key for optimal outcomes.

ALSO READ-One in Eight Women at Risk of Thyroid Disorders

Previous Story

Indian Firms Shine in British Safety Council Awards

Next Story

Udit Narayan Shares ‘Gadar’ Anecdote on ‘Superstar Singer 3’

Latest from Health

Lower BP Target Could Benefit Indians

Beyond salt reduction, experts stressed that controlling hypertension requires a comprehensive approach. Regular exercise, maintaining a healthy body weight, reducing alcohol intake, quitting tobacco, and consuming a balanced diet rich in fruits

Silent Diabetes Crisis Unfolds

The report further highlights that even for those who do receive a diagnosis, the challenges of care and management remain significant A startling number of young adults across the globe are living

Train ASHAs, Save Babies

Speaking to IANS, Dr. Rahul UR, State Nodal Officer – Child Health and Rare Diseases, National Health Mission, Kerala, explained that understanding the disease’s natural course is essential Training India’s network of

WHO Warns of Escalating Cholera Threat

Recent figures highlight the growing threat. In 2023, WHO recorded 535,321 cases and 4,007 deaths across 45 countries. However, the true toll is likely higher, with weak surveillance systems and fears of trade
Go toTop